Collagenase: A Versatile Workhorse in Biomedical Research

In biomedical laboratories, researchers constantly encounter a key challenge: how to isolate intact cells while fully preserving cell viability. Traditional isolation methods frequently cause cellular damage, yet the emergence of collagenase has revolutionized tissue dissociation workflows entirely.

This enzyme specifically hydrolyzes the triple-helical structure of collagen, leaving other proteins and tissue structures intact and undamaged.

01 What is Collagenase?

Collagenase, formally named collagen hydrolase, is an enzyme capable of specifically cleaving the triple helical conformation of native collagen under physiological pH and temperature conditions.

Essentially a protein biomolecule, it is highly susceptible to temperature, pH fluctuation, and all conditions that induce protein denaturation.

Collagenase is categorized into two major groups based on origin: endogenous human collagenase and pharmaceutical-grade collagenase.

• Endogenous collagenase is naturally synthesized in the human body, localized in epithelial tissues such as gingiva and mucous membranes, as well as synovial joints and intervertebral discs.
• Pharmaceutical collagenase is a white or off-white sterile lyophilized biologic product, extracted, purified and refined from the fermentation broth of Clostridium histolyticum via biopharmaceutical processes.

02 Classification of Collagenase Isoforms

Collagenase refers to an enzyme family with multiple subtypes rather than a single enzyme preparation, and each subtype is optimized for distinct experimental applications.

The mainstream commonly used types are listed below:

• Collagenase Type I: Optimized for cell isolation from epithelial tissue, lung, adipose and adrenal glands. It digests interstitial connective tissue to dissociate mammalian tissue into single-cell suspensions.
• Collagenase Type II: Suitable for dissociation of liver, bone, thyroid, cardiac and salivary gland tissues.
• Collagenase Type IV: Contains a mixture of at least 7 protease components with molecular weights ranging from 68 kDa to 130 kDa, enabling efficient digestion of a broad spectrum of tissue types.
• Collagenase Type V: Composed of ≥7 proteases with molecular weights of 68–130 kDa, widely applied for pancreatic islet isolation by breaking down surrounding connective tissue into discrete single cells.

Custom hepatocyte-specific collagenase formulations are also commercially available to meet specialized cell separation requirements.

03 Versatile Applications of Collagenase

Cell Isolation & Tissue Dissociation

Collagenase serves as a core reagent for tissue digestion and primary cell isolation. Trypsin exhibits limited performance for dense tissues rich in connective tissue and collagen matrix, whereas collagenase delivers superior dissociation efficacy for such specimens.

It selectively degrades extracellular stroma with minimal cytotoxicity toward epithelial cells, making it ideal for fibrous tissue, epithelial tissue and tumor digestion to separate epithelial cells from collagen matrices without cellular damage.

Standard working concentration is 200 U/mL (approximately 1 mg/mL), or a mass concentration of 0.03%~0.3%.

Preclinical Disease Model Establishment

Collagenase is extensively utilized to generate animal disease models in preclinical research. For instance, intra-articular collagenase injection is a classic method to establish temporomandibular joint osteoarthritis animal models.

Model construction details: Female castrated Nubian goats weighing 15–20 kg are anesthetized, and 0.5%–1% collagenase solution is injected into the superior joint space at a dosage of 478 U/kg body weight unilaterally.

Obvious pathological joint lesions develop one month post-injection, with pathological deterioration progressing over prolonged observation periods.

Clinical Therapeutic Applications

Collagenase displays remarkable clinical therapeutic value, acting as a core drug for minimally invasive spinal intervention targeting discogenic pain.

Under image-guided positioning, collagenase is precisely injected around herniated intervertebral disc tissue to solubilize collagenous protrusions, relieving spinal nerve compression to alleviate or eliminate neuropathic pain.

Additional research explores its efficacy for preventing prosthetic capsule formation and contracture. Animal studies conducted by the Plastic Surgery Hospital, Chinese Academy of Medical Sciences verified that collagenase effectively degrades collagen fibers within periprosthetic capsules, providing preventive and therapeutic benefits against capsular contracture.

04 Practical Operation Guidelines for Collagenase

Reagent Preparation

Type I collagenase features large molecular aggregates that are difficult to filter with conventional membranes; Seitz filter systems are recommended for sterile filtration.

Notably, calcium ions, magnesium ions and serum supplements do not inhibit collagenase activity. Therefore, BSS buffers (D-Hanks, PBS) or serum-supplemented culture medium can be adopted as dilution solvents.

Tissue Digestion Protocol

Trim thoroughly rinsed tissue into small cubes of approximately 1–2 mm³. Transfer tissue fragments into centrifuge tubes or triangular flasks, add collagenase solution at a volume ratio of 1:30~1:50, and seal the container tightly.

Incubate samples in a 37°C water bath or incubator, vortex briefly every 3 minutes; a thermostatted shaking water bath at 37°C delivers optimal digestion performance.

Incubation duration varies drastically by tissue type: dense tumor tissue and tough connective tissue require 4–48 hours of digestion, while soft tissue can be fully dissociated within 15–45 minutes with shaking incubation at 37°C.

Digestion Termination & Cell Harvesting

Complete digestion is confirmed when intact tissue fragments collapse into loose cell aggregates or single cells upon gentle agitation.

Epithelial cells exhibit innate tolerance to collagenase treatment, so partial cell clusters commonly remain post-digestion; epithelial cell aggregates generally demonstrate superior proliferation capacity compared to fully dissociated single cells.

Collect the digested supernatant; pass through a 100-mesh stainless steel sieve to remove residual undigested tissue debris if necessary. Centrifuge at 1000 rpm for 5 minutes, discard supernatant, wash cell pellets 1–2 times with Hanks' balanced salt solution or serum-free medium by repeated centrifugation, resuspend cells in complete medium, and seed into culture flasks for incubation.

05 Typical Research Applications of Collagenase

Intervertebral Disc Research

A 2005 study from Tianjin Medical University investigated the morphological effects of graded collagenase concentrations on cultured human degenerative and rabbit normal intervertebral disc tissues and cells.

Sterilely resected disc specimens were cultured in high-glucose DMEM supplemented with 20% fetal bovine serum and TGF-β growth factor.

200 μL collagenase at concentrations of 200 U/mL and 400 U/mL was added to respective groups. Morphological alterations were recorded at 24 h, 48 h and 1 week, and collagenolytic efficacy was quantified via wet weight measurement and viable cell counting.

Corneal Disease Therapy Research

A 2019 clinical research project at National Taiwan University Hospital evaluated collagenase A for limbal stem cell isolation in corneal disease treatment.

Dispase II / Trypsin-EDTA was replaced with collagenase A in the limbal stem cell isolation workflow, eliminating the requirement for feeder cell co-culture.

This optimized protocol is termed Collagenase A-Assisted Cultivated Oral Mucosal Epithelial Transplantation (CA-COMET), offering an innovative therapeutic strategy for bilateral total limbal stem cell deficiency.

Oncology Research

Collagenase Type IV is widely applied in cancer metastasis research. Orthotopic and ectopic hepatocellular carcinoma mouse models were established via subcapsular liver injection and subcutaneous injection of tumor cell suspensions respectively.

Substrate zymography was used to quantify Type IV collagenase specific activity across model groups, exploring the molecular mechanism underlying enhanced metastatic potential in orthotopic liver tumor xenografts.

Collagenase possesses extensive developmental potential in academic research and clinical treatment. Continuous advances in biotechnology deepen our mechanistic understanding of this protease family year by year.

In the future, this powerful biological reagent is expected to drive groundbreaking breakthroughs in tissue engineering, regenerative medicine and precision disease therapy. Though seemingly modest, collagenase continuously propels the progression of modern medical research.

Absin Collagenase Product Recommendation

Contact Absin

Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

Absin Bioscience Inc. worldwide@absin.cn

Follow us on Facebook: Absin Bio